EvoEndo

EvoEndo is a preclinical stage medical device company based in Centennial, Colorado, focused on developing innovative systems for unsedated endoscopic procedures, particularly for pediatric patients. Founded in 2017, the company aims to enhance patient comfort and safety by providing a sedation-free, lower-risk, and cost-effective alternative to traditional endoscopy. The flagship product, the EvoEndo® Single-Use Unsedated Endoscopy System, features a single-use, ultra-thin, flexible endoscope with four-way steering and a portable controller that delivers advanced image quality. It also includes a virtual reality-based patient distraction system to facilitate sedation-free procedures. This system is the only FDA-cleared device specifically designed for pediatric use, allowing for both transnasal and traditional transoral endoscopy without the need for sedation. EvoEndo's technology aligns with the 2025 American College of Gastroenterology Guidelines for Eosinophilic Esophagitis, promoting safer and more patient-centered care. The company is supported by a diverse team of professionals and has raised significant funding to further its mission of making endoscopies safer and more accessible for children.

• Employees 19
• Founded 2017
• Annual Revenue $4200000
• Total Funding $22700000